PubRank

J Eisinger

Author PubWeight™ 79.11‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The orientational freedom of molecular probes. The orientation factor in intramolecular energy transfer. Biophys J 1979 5.24
2 A milling crowd model for local and long-range obstructed lateral diffusion. Mobility of excimeric probes in the membrane of intact erythrocytes. Biophys J 1986 2.39
3 Behavioral indicators of lead neurotoxicity: results of a clinical field survey. Int Arch Occup Environ Health 1978 1.75
4 Intramolecular energy transfer in adrenocorticotropin. Biochemistry 1969 1.68
5 Prevalence of lead disease among secondary lead smelter workers and biological indicators of lead exposure. Environ Res 1977 1.66
6 Biological molecules in their excited states. Nature 1970 1.64
7 Zinc protoporphyrin level in blood determined by a portable hematofluorometer: a screening device for lead poisoning. J Lab Clin Med 1977 1.60
8 Lead poisoning due to hai ge fen. The porphyrin content of individual erythrocytes. JAMA 1994 1.49
9 Intramolecular energy transfer and molecular conformation. Proc Natl Acad Sci U S A 1976 1.47
10 Lateral mobility of lipid analogues and GPI-anchored proteins in supported bilayers determined by fluorescent bead tracking. J Membr Biol 1993 1.44
11 Excimer fluorescence of dinucleotides, polynucleotides, and DNA. Proc Natl Acad Sci U S A 1966 1.35
12 Intramolecular singlet excitation transfer. Applications to polypeptides. Biochemistry 1969 1.30
13 Lead effects among secondary lead smelter workers with blood lead levels below 80 microgram/100 ml. Arch Environ Health 1978 1.27
14 Fluorescence quenching and isotope effect of tryptophan. J Chem Phys 1969 1.20
15 The hematofluorometer. Clin Chem 1977 1.19
16 Excited electronic states of DNA. Science 1968 1.19
17 Letter: interpretation of intramolecular energy transfer experiments. J Mol Biol 1974 1.18
18 The anticodon-anticodon complex. J Mol Biol 1974 1.14
19 Representation and high-quality annotation of the Physcomitrella patens transcriptome demonstrates a high proportion of proteins involved in metabolism in mosses. Plant Biol (Stuttg) 2005 1.13
20 Central nervous system dysfunction due to lead exposure. Science 1978 1.12
21 Front-face fluorometry of liquid samples. Anal Biochem 1979 1.11
22 Codon-anticodon binding in tRNAphe. Nat New Biol 1971 1.09
23 A variable temperature, U.V. luminescence spectrograph for small samples. Photochem Photobiol 1969 1.09
24 Flurorometric study of the partition of bilirubin among blood components: basis for rapid microassays of bilirubin and bilirubin binding capacity in whole blood. Anal Biochem 1979 1.08
25 Energy transfer in tRNA phe (yeast). The solution structure of transfer RNA. Biopolymers 1974 1.07
26 Effects of spatial variation in membrane diffusibility and solubility on the lateral transport of membrane components. Biophys J 1986 1.06
27 Synthetic spectroscopic models related to coenzymes and base pairs. II. Evidence for intramolecular base-base interactions in dinucleotide analog. J Am Chem Soc 1968 1.05
28 Luminescence and binding studies on tRNA-Phe. Proc Natl Acad Sci U S A 1970 1.05
29 Excited states of nucleotides and singlet energy transfer in polynucleotides. J Chem Phys 1967 1.04
30 Complex formation between transfer RNA'S with complementary anticodons. Biochem Biophys Res Commun 1971 1.03
31 Lead and wine. Eberhard Gockel and the colica Pictonum. Med Hist 1982 1.01
32 Triplet state of DNA. J Chem Phys 1967 1.01
33 Association of cytosol hemoglobin with the membrane in intact erythrocytes. Proc Natl Acad Sci U S A 1982 1.01
34 Cytosol-membrane interface of human erythrocytes. A resonance energy transfer study. Biophys J 1983 1.01
35 Dipyrenylphosphatidylcholines as membrane fluidity probes. Relationship between intramolecular and intermolecular excimer formation rates. Biophys J 1990 0.98
36 Luminescence and electron spin resonance studies of adenine in various polynucleotides. J Chem Phys 1966 0.98
37 Lateral diffusivity of lipid analogue excimeric probes in dimyristoylphosphatidylcholine bilayers. Biophys J 1990 0.97
38 The cytosol-membrane interface of normal and sickle erythrocytes. Effect of hemoglobin deoxygenation and sickling. J Biol Chem 1984 0.97
39 Hemoglobin, serum iron, and zinc protoporphyrin in lead-exposed workers. Environ Health Perspect 1978 0.96
40 On the mechanism of thymine photodimerization. Proc Natl Acad Sci U S A 1968 0.96
41 [Silicon, bone tissue and immunity]. Rev Rhum Mal Osteoartic 1980 0.95
42 Binding of complementary pentanucleotides to the anticodon loop of transfer RNA. J Mol Biol 1973 0.92
43 Fluorescence polarization study of human erythrocyte membranes with 1-phenyl-3-(2-naphthyl)-2-pyrazoline as orientational probe. Biochim Biophys Acta 1981 0.89
44 Fluorometry of turbid and absorbant samples and the membrane fluidity of intact erythrocytes. Biophys J 1985 0.88
45 Binding constants from zone transport of interacting molecules. Biochemistry 1973 0.88
46 Energy transfer and dynamical structure. Q Rev Biophys 1976 0.87
47 The excited-state precursor of the thymine dimer. Biochem Biophys Res Commun 1967 0.87
48 [Hydroxyprolinuria during algodystrophies. Therapeutic conclusions]. Rev Rhum Mal Osteoartic 1974 0.87
49 Quantitative determination of erythrocyte zinc protoporphyrin. J Lab Clin Med 1977 0.86
50 [Should patients with fibromyalgia be doped?]. Rev Med Interne 1996 0.85
51 Resonance energy transfer from a cylindrical distribution of donors to a plane of acceptors. Location of apo-B100 protein on the human low-density lipoprotein particle. Biophys J 1990 0.84
52 Fluorescent cytoplasm and Heinz bodies of hemoglobin Köln erythrocytes: evidence for intracellular heme catabolism. Blood 1985 0.83
53 The relative locations of intramembrane fluorescent probes and of the cytosol hemoglobin in erythrocytes, studied by transverse resonance energy transfer. Biophys J 1982 0.83
54 A rapid fluorometric method for determining bilirubin levels and binding in the blood of neonates: comparisons with a diazo method and with 2-(4'-hydroxybenzene)azobenzoic acid dye binding. Pediatrics 1980 0.82
55 Visible gel electrophoresis and the determination of association constants. Biochem Biophys Res Commun 1971 0.82
56 Erythrocyte protoporphyrin/heme ratio by hematofluorometry. Clin Chem 1980 0.82
57 Rapid fluorometric assay of bilirubin and bilirubin binding capacity in blood of jaundiced neonates: comparisons with other methods. Pediatrics 1980 0.82
58 Biochemistry and measurement of environmental lead intoxication. Q Rev Biophys 1978 0.82
59 The ethics of human gene manipulation. Introductory remarks. Fed Proc 1975 0.81
60 Zinc protoporphyrin in blood as a biological indicator of chronic lead intoxication. J Environ Pathol Toxicol 1979 0.81
61 [Intermittent treatment of Paget's disease of bone with calcitonin: histological study]. Rev Rhum Mal Osteoartic 1976 0.81
62 Zinc protoporphyrin determination: a rapid screening test for the detection of lead poisoning. Mt Sinai J Med 1976 0.81
63 Energy transfer in dinucleotides. Proc Natl Acad Sci U S A 1966 0.81
64 Alcohol, thiamin and fibromyalgia. J Am Coll Nutr 1998 0.80
65 Lateral diffusion of phospholipids in the lipid surface of human low-density lipoprotein measured with a pyrenyl phospholipid probe. Eur J Biochem 1989 0.80
66 The distribution of intracellular calcium chelator (fura-2) in a population of intact human red cells. Biochim Biophys Acta 1993 0.80
67 [Sleep apnea and fibromyalgia: the absence of correlation does not indicate an exclusive central hypothesis]. Rev Med Interne 1995 0.77
68 Synthetic spectroscopic models related to coenzymes and base pairs. IV. Stacking interactions in tRNA; the anticodon-adjacent base. Proc Natl Acad Sci U S A 1969 0.76
69 Regarding evaluation of zinc protoporphyrin. Am Ind Hyg Assoc J 1980 0.75
70 Modulation of lateral transport of membrane components by spatial variations in diffusivity and solubility. Biophys J 1992 0.75
71 Synthetic spectroscopic models related to coenzymes and base pairs. VII. Stacking interactions in tRNA; the "bend" at dimethylguanosine. Proc Natl Acad Sci U S A 1970 0.75
72 Thiamin and cognitive impairment. J Am Coll Nutr 1997 0.75
73 [On the treatment of osteoporosis: new physiopathological dats. Treatment with calcium and hydergine]. Mars Med 1966 0.75
74 Energy transfer in poly dAT. J Mol Biol 1967 0.75
75 [Current trends in phosphotherapy. IV. Treatment of oxalic lithiasis]. Mars Med 1971 0.75
76 [4. Exploration of phosphorus and calcium metabolism in 40 arteritis patients]. Mars Med 1968 0.75
77 [Therapeutic sequences calcitonin-EHDP and EHDP-calcitonin in Paget's disease. Histological and biological study]. Rev Rhum Mal Osteoartic 1986 0.75
78 Lead poisoning from cocktail glasses. JAMA 1977 0.75
79 [The calcitonin-induced hypocalcemia test. For a simplified protocol]. Rev Rhum Mal Osteoartic 1984 0.75
80 [Albumino-cytologic reaction in polyradiculoneuritis]. Mars Med 1966 0.75
81 [Physiologic considerations on vasomotro innervation of bones]. Mars Med 1967 0.75
82 [Treatment of hypercalcemia in adults]. Mars Med 1970 0.75
83 [Dense bone metastases and hypophosphatemic osteomalacia during the course of prostatic cancer (author's transl)]. Sem Hop 1981 0.75
84 [Peripheral circulation and osseous metabolism. 1. Effects of vasodilator treatment]. Mars Med 1968 0.75
85 Environmental intoxicants and their fundamental interactions. Q Rev Biophys 1978 0.75
86 [HL-A and Paget's disease]. Rev Rhum Mal Osteoartic 1975 0.75
87 Living with lead. Nature 1979 0.75
88 Distribution of erythrocyte free porphyrin content in erythropoietic protoporphyria. J Lab Clin Med 1992 0.75
89 [Treatment of hypercalcemia with Mithramycin]. Mars Med 1972 0.75
90 [The bones in myopathies]. Sem Hop 1967 0.75
91 [Mithramycin in the treatment of hypercalcemia and Paget's disease]. Rev Rhum Mal Osteoartic 1973 0.75
92 [Comparison of the immediate hypocalcemia effect of salmon calcitonin administered by spray or intravenously]. Rev Rhum Mal Osteoartic 1985 0.75
93 [Neurofibromatosis and vitamin-resistant osteomalacia (apropos of a case)]. Mars Med 1970 0.75
94 [Biological monitoring during treatments of systemic osteoporosis. Therapeutic deductions]. Rev Rhum Mal Osteoartic 1971 0.75
95 [Current trends of phosphotherapy. VII. Conclusion]. Mars Med 1972 0.75
96 [Current trends of phosphotherapy]. Mars Med 1970 0.75
97 [Clinical tolerance of calcitonin as a function of the mode of administration. Value of non-injectable forms]. Rev Rhum Mal Osteoartic 1987 0.75
98 [Diaphyseal osseous innervation and circulation]. Rev Rhum Mal Osteoartic 1967 0.75
99 The excited states of DNA. Adv Biol Med Phys 1968 0.75
100 [Diagnosis of osseous microgeodes]. Mars Med 1968 0.75
101 [Hydroxyprolinuria in the normal person]. Rhumatologie 1969 0.75
102 [Biological exploration of Paget's disease]. Rev Rhum Mal Osteoartic 1976 0.75
103 [Vitamin D]. Mars Med 1972 0.75
104 [Apropos of the effects of sympathetic interventions on phosphocalcic metabolism]. Rhumatologie 1966 0.75
105 [Symptomatology of intermittent claudication type in radicular and muscular diseases]. Mars Med 1966 0.75
106 [3. Effect of sympathectomy on blood calcium in clinical medicine]. Mars Med 1968 0.75
107 Vitamin B6 and magnesium. Magnesium 1986 0.75
108 [Current trends of phosphotherapy. VI. Treatment of corticoid-induced osteoporosis]. Mars Med 1972 0.75
109 Lead hazard among ironworkers. Dismantling lead-painted elevated subway line in New York City. N Y State J Med 1978 0.75
110 [Action of phenylbutazone on phospho-calcic metabolism]. Mars Med 1968 0.75
111 [2. Effects of experimental sympathectomy on phosphorus and calcium metabolism]. Mars Med 1968 0.75
112 Bilirubin sensitivity of zinc protoporphyrin hematofluorometers. J Lab Clin Med 1979 0.75
113 [Fibromyalgia: non-entity or double agent?]. Rev Med Interne 2001 0.75
114 [Value of the therapeutic sequence calcitonin-EHDP in Paget's disease]. Rev Rhum Mal Osteoartic 1983 0.75
115 [Congenital stricture of the lumbar rachidian canal with intermittant symptomatology]. Rhumatologie 1966 0.75
116 [Disorders of calcium metabolism during Paget's disease: new technics of exploration]. Sem Hop 1977 0.75
117 [Modifications of urinary hydroxyproline by therapeutic measures with vascular effects (apropos of 25 cases)]. Rhumatologie 1969 0.75
118 [Trial of acetic (methyl-10-phenothiazinyl) acid in rheumatology]. Mars Med 1969 0.75
119 [Current trends in phosphotherapy. V. Urinary acidity and phosphorus]. Mars Med 1971 0.75
120 [Biological abnormalities in fibromyalgia: a new therapeutic approach?]. Rev Rhum Ed Fr 1994 0.75
121 Repetitive electromyographic activity, spasmorhythmia and spasmophilia. Magnesium 1987 0.75
122 Distribution of non-heme porphyrin content of individual erythrocytes by fluorescence image cytometry and its application to lead poisoning. Cytometry 1992 0.75
123 [Anabolizing agents and phosphocalcic metabolism]. Mars Med 1972 0.75
124 [Biological and isotope explorations in Paget's disease of bone]. Rhumatologie 1971 0.75
125 [Dosage of ionized calcium in osteo-articular pathology]. Rev Rhum Mal Osteoartic 1978 0.75